HK1048492A1 - Hbv sequences - Google Patents

Hbv sequences

Info

Publication number
HK1048492A1
HK1048492A1 HK02108309.7A HK02108309A HK1048492A1 HK 1048492 A1 HK1048492 A1 HK 1048492A1 HK 02108309 A HK02108309 A HK 02108309A HK 1048492 A1 HK1048492 A1 HK 1048492A1
Authority
HK
Hong Kong
Prior art keywords
hbv sequences
hbv
sequences
Prior art date
Application number
HK02108309.7A
Other languages
Chinese (zh)
Inventor
Stuyver Lieven
Van Geyt Caroline
De Gendt Sija
Original Assignee
Innogenetics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP99870252A external-priority patent/EP1104811A1/en
Application filed by Innogenetics Nv filed Critical Innogenetics Nv
Publication of HK1048492A1 publication Critical patent/HK1048492A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK02108309.7A 1999-12-03 2002-11-15 Hbv sequences HK1048492A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99870252A EP1104811A1 (en) 1999-12-03 1999-12-03 HBV sequences
US16928799P 1999-12-07 1999-12-07
PCT/EP2000/011526 WO2001040279A2 (en) 1999-12-03 2000-11-20 Hbv sequences

Publications (1)

Publication Number Publication Date
HK1048492A1 true HK1048492A1 (en) 2003-04-04

Family

ID=26153865

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02108309.7A HK1048492A1 (en) 1999-12-03 2002-11-15 Hbv sequences

Country Status (6)

Country Link
EP (1) EP1234040A2 (en)
JP (1) JP2003515327A (en)
AU (1) AU2358201A (en)
CA (1) CA2392853A1 (en)
HK (1) HK1048492A1 (en)
WO (1) WO2001040279A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003106714A1 (en) * 2002-06-14 2003-12-24 Gen-Probe Incorporated Compositions and methods for detecting hepatitis b virus
ATE473997T1 (en) 2002-09-06 2010-07-15 Advanced Life Science Inst Inc HBV PRECORE PROTEIN CAPABILITY TO FORM PARTICLES
US8575327B2 (en) 2003-06-12 2013-11-05 Alnylam Pharmaceuticals, Inc. Conserved HBV and HCV sequences useful for gene silencing
WO2004113369A1 (en) 2003-06-20 2004-12-29 Dade Behring Marburg Gmbh Novel surface protein (hbsag) variant of hepatitis b virus
CA2529997A1 (en) 2003-06-20 2004-12-29 Dade Behring Marburg Gmbh Novel surface protein (hbsag) variant of hepatitis b virus
DE10339927A1 (en) * 2003-08-29 2005-03-24 Rhein Biotech Gesellschaft für neue Biotechnologische Prozesse und Produkte mbH Composition for the prophylaxis / therapy of HBV infections and HBV-mediated diseases
JP2008525029A (en) * 2004-12-22 2008-07-17 ニュークレオニクス・インコーポレイテッド HBV and HCV conserved sequences useful for gene silencing
PE20140844A1 (en) 2011-02-12 2014-07-14 Globeimmune Inc YEAST-BASED THERAPEUTICS FOR CHRONIC HEPATITIS B INFECTION
EP3816288A3 (en) 2011-04-21 2021-07-14 Glaxo Group Limited Modulation of hepatitis b virus (hbv) expression
US9045803B2 (en) 2012-02-29 2015-06-02 Abbott Molecular Inc. Hepatitis B virus typing and resistance assay
JOP20200092A1 (en) 2014-11-10 2017-06-16 Alnylam Pharmaceuticals Inc HEPATITIS B VIRUS (HBV) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
US11324820B2 (en) 2017-04-18 2022-05-10 Alnylam Pharmaceuticals, Inc. Methods for the treatment of subjects having a hepatitis b virus (HBV) infection
CA3106701A1 (en) 2018-08-13 2020-02-20 Alnylam Pharmaceuticals, Inc. Hepatitis b virus (hbv) dsrna agent compositions and methods of use thereof
CN114514427A (en) 2019-09-27 2022-05-17 富士瑞必欧株式会社 Immunoassay of hepatitis b virus core-associated antigen and kit for same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07506254A (en) * 1992-05-06 1995-07-13 ジェン−プローブ・インコーポレイテッド Nucleic acid amplification oligonucleotides and probes for human hepatitis B virus
US5736334A (en) * 1993-04-12 1998-04-07 Abbott Laboratories Nucleotide sequences and process for amplifying and detection of hepatitis B viral DNA

Also Published As

Publication number Publication date
AU2358201A (en) 2001-06-12
CA2392853A1 (en) 2001-06-07
WO2001040279A3 (en) 2002-01-10
JP2003515327A (en) 2003-05-07
EP1234040A2 (en) 2002-08-28
WO2001040279A2 (en) 2001-06-07

Similar Documents

Publication Publication Date Title
DE60040066D1 (en) Gen
EP1118915A4 (en) Time piece
IL149840A0 (en) New aminopropylphosphinic acids
HK1048492A1 (en) Hbv sequences
GB9905817D0 (en) Methods
GB9926161D0 (en) Methods
GB9905512D0 (en) Process
GB9800536D0 (en) Sequences
GB0011459D0 (en) Sequences
GB9904162D0 (en) Process
GB0008801D0 (en) Sequences
GB9905418D0 (en) Process
GB9903087D0 (en) Process
TW433433U (en) Improved lampstand
GB9914943D0 (en) Methods
GB9908525D0 (en) Methods
EG22401A (en) Set 3c1-strong
GB9821428D0 (en) Sequences
GB9910348D0 (en) Novel DNA sequences
GB9918588D0 (en) Sequence
GB9910369D0 (en) Sequence
GB9901471D0 (en) Selection process
GB9905651D0 (en) Pot
IL128276A0 (en) Marble
IL132459A0 (en) Brain specific sequences